Why BioCryst Pharmaceuticals Stock Is Soaring Today
Shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) were soaring 14.5% higher as of 10:51 a.m. EDT on Thursday. The big gain came after the drugmaker provided its first-quarter update before the market opened.
BioCryst had plenty of good news to share in its quarterly update. The company reported total revenue in Q1 of $19.1 million, more than doubling the consensus Wall Street revenue estimate of $8.9 million.
Image source: Getty Images.
Source Fool.com


